Prevnos
Biotechnology, 2451 Steuben St, Union, New Jersey, 07083, United States, 1-10 Employees
Who is PREVNOS
Prevnos is a biotechnology company operating within the in vitro diagnostics sector. Prevnos engages within the cancer genetics and cytogenetics space, creating novel fluorescence in situ...
Read More
-
Headquarters: 2451 Steuben St, Union, New Jersey, 07083, United States
-
Date Founded: 2016
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Prevnos
Answer: Prevnos's headquarters are located at 2451 Steuben St, Union, New Jersey, 07083, United States
Answer: Prevnos's official website is https://prevnos.com
Answer: Prevnos's revenue is Under $1 Million
Answer: Prevnos's SIC: 2836
Answer: Prevnos's NAICS: 541714
Answer: Prevnos has 1-10 employees
Answer: Prevnos is in Biotechnology
Answer: Prevnos contact info: Phone number: Website: https://prevnos.com
Answer: Prevnos is a biotechnology company operating within the in vitro diagnostics sector. Prevnos engages within the cancer genetics and cytogenetics space, creating novel fluorescence in situ hybridization (FISH) assays for clinical and research use. As the inventors of the world's first Hybrid Fusion FISHTM tests for cancer genetics and diagnostics, Prevnos enables 90%+ efficiency in FISH testing while reducing the overall economic burden for such tests. Prevnos is also the inventor of the Retina MicroscopeTM, the world's most economical and first fluorescence scope to use transparent OLED displays and foil-glass projection displays operating through a thin-client PC, conveniently and optimally suited for a FISH dark room. It is the first FISH scope in its class. Our mission is to make preventive healthcare a priority through early detection and active surveillance via simple and cost-effective screening tools. Prevnos uses "colored dots" (DOTTM - Dynamic Optical Transmission) to identify cancer genes for disease stratification. These colored dots are quantifiable, with specific signal patterns indicating the stage of the disease (i.e. aggressive vs. indolent, benign vs. metastasis). Such actionable information can also be tethered to clinical utility (i.e. ALK FISH for FDA-approved Xalkori). Prevnos' Hybrid Fusion FISHTM tests allow for controlled outcomes to select appropriate and tailored treatment options. Prevnos has characterized 100+ "colored dots" (Hybrid Fusion FISHTM tests) that are implicated in multiple cancers and has created specific panels for each disease. Prevnos also utilizes it's Hybrid Fusion FISHTM technology for operations within the energy sector in the industrial oil fracking industry to increase the efficiency of natural gas collection and purification.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month